FDCP
PFE icon

Foster Dykema Cabot & Partners’s Pfizer PFE Stock Holding History

Foster Dykema Cabot & Partners’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$124K Hold
5,130
– – 0.01% 139
2026
Q1 		$144K Hold
5,130
– – 0.01% 131
2025
Q4 		$128K Buy
5,130
+60
+1% +$1.51K 0.01% 146
2025
Q3 		$129K Sell
5,070
-1,625
-24% -$40.1K 0.01% 155
2025
Q2 		$162K Hold
6,695
– – 0.01% 138
2025
Q1 		$170K Hold
6,695
– – 0.01% 129
2024
Q4 		$178K Sell
6,695
-164
-2% -$4.45K 0.01% 133
2024
Q3 		$198K Sell
6,859
-736
-10% -$21.5K 0.02% 128
2024
Q2 		$213K Sell
7,595
-192
-2% -$5.29K 0.02% 94
2024
Q1 		$216K Buy
7,787
+1,076
+16% +$29.9K 0.02% 97
2023
Q4 		$193K Buy
+6,711
New +$203K 0.02% 92

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Foster Dykema Cabot & Partners's PFE Position: Q2 2026 in Review

Foster Dykema Cabot & Partners held its Pfizer (PFE) position steady in Q2 2026 at 5,130 shares worth $124K. The position accounts for 0.01% of the portfolio, ranked #139.

Foster Dykema Cabot & Partners first reported a position in PFE in Q4 2023 and has held it in 11 quarters since. The position peaked at $216K in Q1 2024. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Foster Dykema Cabot & Partners held 5,130 shares of Pfizer worth $124K as of Q2 2026.
  • Foster Dykema Cabot & Partners left its Pfizer share count unchanged in Q2 2026.
  • Pfizer made up 0.01% of Foster Dykema Cabot & Partners's portfolio in Q2 2026, its #139 holding.
  • Foster Dykema Cabot & Partners first reported a position in Pfizer in Q4 2023 and has held it in 11 quarters since.
  • Foster Dykema Cabot & Partners's Pfizer position peaked at $216K in Q1 2024.
  • 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Foster Dykema Cabot & Partners's 13F filing for Q2 2026, filed 11 Aug 2026.